Oxytocin in Spectrum Autism Disorders

• Status: Completed
• Trial end date: 2018-05-15
• Target enrollment: 0
• Participant gender: All

Summary

Observe effects of oxytocin on individuals with autism spectrum disorder

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo General Hospital
• Treatments: Oxytocin

Criteria

Inclusion Criteria:Diagnosis of ASD by DSMV

• CARS> 30

• age between 3 and 16 years

• stable (3 months with medication maintained or without medication)

Exclusion Criteria:- pregnant women, infants and

• participation in another research project of pharmacological or behavioral intervention in progress

• Use of pituitary hormones, cortisol, androgens and estrogens.

• heart problems: recent AMI, heart failure.

• respiratory problems: pneumonia, respiratory failure, decompensated asthma, acute bronchitis.